REINVENTING THERAPEUTICS. REVITALIZING HEALTHCARE.
Roivant Sciences is a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the lives of patients and their families.
WHO WE ARE
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. We are a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.
Roivant Sciences has a special interest in the following disease categories, where we have deep in-house expertise:
Members of our development team have achieved FDA approval for 7 New Drug Applications on industry-beating timelines, including blockbuster products such as Aricept®, Aciphex®, and Sovaldi®.
WHO WE WORK WITH
Roivant Sciences has strategic alliances with partners who share our patient-centric commitment to develop promising drug candidates into approved medicines. Our company delivers R&D solutions to our biopharmaceutical industry partners, enabling them to unlock value from their pipelines and scale their businesses.
Roivant seeks late-stage drug candidates with the potential for accelerated regulatory approval timelines, where our significant capital base and world-class development expertise can maximize the opportunity for these drugs to positively impact the lives of patients. Our company will selectively evaluate regional or global product opportunities across all therapeutic areas, mechanisms of action, routes of administration, and levels of innovativeness.
GET IN TOUCH
2 Church Street
Hamilton HM 11
55 Par-La-Ville Road
Hamilton HM 11
320 West 37th Street
New York, NY 10018